Remarkably, our findings revealed a significant difference for the TERT*(rs2736098; c.915G > A) variant and elevated risk of HCC under allelic, recessive, and dominant models (OR = 1.83, 2.31, and 2.54, respectively). This evidence concerns the gene TERT and hepatocellular carcinoma.